Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam tosylate for perioperative stress and immune function in radical mastectomy
ChiCTR2100044750Phase 4Recruiting
- Sponsor
- Liaoning Province Cancer Hospital
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam in breast cancer (4 arms), sponsored by Liaoning Province Cancer Hospital. Primary endpoints: T lymphocyte subsets in peripheral blood, Th1 cytokine IFN-gamma and 1 more. Started Mar 2021; status: recruiting.
02
Drugs
remimazolam
03
Conditions
breast cancer
Beyond the preview
Go deeper on ChiCTR2100044750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100044750.